These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 1412200

  • 1. Pharmacological profile of G619, a new platelet aggregation inhibitor.
    Yue TL, Smith EF, Ohlstein EH, Sulpizio A, Slivjak MJ, Rabinovici R, Sellers TS, Lynch KM, Poyser R, Feuerstein G.
    Thromb Res; 1992 May 15; 66(4):331-47. PubMed ID: 1412200
    [Abstract] [Full Text] [Related]

  • 2. Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
    Ding YA, Chou TC, Chern JW, Yen MH.
    Thromb Res; 1995 Feb 01; 77(3):291-303. PubMed ID: 7740521
    [Abstract] [Full Text] [Related]

  • 3. Antiplatelet actions of some coumarin compounds isolated from plant sources.
    Teng CM, Li HL, Wu TS, Huang SC, Huang TF.
    Thromb Res; 1992 Jun 01; 66(5):549-57. PubMed ID: 1523611
    [Abstract] [Full Text] [Related]

  • 4. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S, Westwick J, Kakkar VV.
    Biochem Pharmacol; 1984 Oct 01; 33(19):3025-35. PubMed ID: 6091666
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr.
    Ko FN, Hsiao G, Chen IS, Wu SJ, Teng CM.
    Biochem Pharmacol; 1993 Oct 05; 46(7):1165-73. PubMed ID: 8216367
    [Abstract] [Full Text] [Related]

  • 6. Effects of free and macromolecular-bound TXA2 receptor antagonist BM 13.505 on U46619-induced platelet aggregation.
    Klimm JL, Kloczewiak MA, Lindon J.
    Prostaglandins; 1993 Jul 05; 46(1):27-36. PubMed ID: 8378540
    [Abstract] [Full Text] [Related]

  • 7. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A, Kawakage M, Shirakura S, Higo K, Kubo K, Ohshima E, Obase H.
    Arzneimittelforschung; 1991 Dec 05; 41(12):1230-6. PubMed ID: 1840011
    [Abstract] [Full Text] [Related]

  • 8. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
    Yu SM, Chen CC, Ko FN, Huang YL, Huang TF, Teng CM.
    Biochem Pharmacol; 1992 Jan 22; 43(2):323-9. PubMed ID: 1310852
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM, Wu TS, Teng CM.
    Br J Pharmacol; 1994 Mar 22; 111(3):906-12. PubMed ID: 8019768
    [Abstract] [Full Text] [Related]

  • 10. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML, Packham MA, Kinlough-Rathbone RL, Fraser Mustard J.
    Thromb Haemost; 1988 Jun 16; 59(3):383-7. PubMed ID: 3142075
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of 3-[2-(cyclopropylamino)ethoxy]xanthone on platelet thromboxane formation.
    Chen WY, Ko FN, Lin CN, Teng CM.
    Thromb Res; 1994 Jul 01; 75(1):81-90. PubMed ID: 8073410
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S, Nakahata N, Ohizumi Y.
    Br J Pharmacol; 1996 Mar 01; 117(6):1095-104. PubMed ID: 8882602
    [Abstract] [Full Text] [Related]

  • 15. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T, Tomiyama Y, Honda S, Senzaki K, Tanaka A, Okubo M, Takahashi F, Takasugi H, Seki J.
    Thromb Haemost; 1998 Jun 01; 79(6):1184-90. PubMed ID: 9657446
    [Abstract] [Full Text] [Related]

  • 16. PAF antagonism in vitro and in vivo by aglafoline from Aglaia elliptifolia Merr.
    Ko FN, Wu TS, Liou MJ, Huang TF, Teng CM.
    Eur J Pharmacol; 1992 Jul 21; 218(1):129-35. PubMed ID: 1327822
    [Abstract] [Full Text] [Related]

  • 17. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C, Rousselot C, Chavernac G, Depin JC, Guerrier D.
    Arzneimittelforschung; 1994 Nov 21; 44(11):1196-202. PubMed ID: 7848331
    [Abstract] [Full Text] [Related]

  • 18. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
    Chang TS, Kim HM, Lee KS, Khil LY, Mar WC, Ryu CK, Moon CK.
    Biochem Pharmacol; 1997 Jul 15; 54(2):259-68. PubMed ID: 9271330
    [Abstract] [Full Text] [Related]

  • 19. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD, Seewaldt-Becker E, Himmelsbach F, Weisenberger H, Müller TH.
    J Cardiovasc Pharmacol; 1997 Aug 15; 30(2):261-72. PubMed ID: 9269956
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.